1. Home
  2. ARMP vs LARK Comparison

ARMP vs LARK Comparison

Compare ARMP & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

SELL

Current Price

$3.02

Market Cap

199.7M

Sector

Health Care

ML Signal

SELL

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

SELL

Current Price

$32.23

Market Cap

190.1M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ARMP
LARK
Founded
N/A
1885
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
190.1M
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
ARMP
LARK
Price
$3.02
$32.23
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
★ 75.7K
4.4K
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
★ 2.63%
EPS Growth
N/A
★ 35.84
EPS
N/A
★ 2.59
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$12.36
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$23.57
52 Week High
$14.98
$34.60

Technical Indicators

Market Signals
Indicator
ARMP
LARK
Relative Strength Index (RSI) 46.59 54.16
Support Level $2.77 $30.92
Resistance Level $3.96 $33.13
Average True Range (ATR) 0.44 0.32
MACD -0.02 -0.00
Stochastic Oscillator 43.35 85.42

Price Performance

Historical Comparison
ARMP
LARK

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.

Share on Social Networks: